EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Durable Response to Sotorasib Plus Panitumumab in NRAS G12C-Mutated, Microsatellite Instability-High (MSI-H) Rectal Cancer Refractory to Immunotherapy

Latif Karahan, Sevtap Arslan, Omer Dizdar

Cureus · 07.06.2026

DOI: 10.7759/cureus.110414 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 07.06.2026. Verfasst von Latif Karahan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Hacettepe University Cancer Institute, Ankara, TUR. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

durable responseimmunotherapymsi-highnras g12c mutationrectal cancersotorasib and panitumumab

Autor:innen und Institutionen

  • Medical Oncology, Hacettepe University Cancer Institute, Ankara, TUR.
  • Department of Radiology, Hacettepe University Faculty of Medicine, Ankara, TUR.

Zitieren

APA

Karahan, L., Arslan, S., & Dizdar, O. (2026). Durable Response to Sotorasib Plus Panitumumab in NRAS G12C-Mutated, Microsatellite Instability-High (MSI-H) Rectal Cancer Refractory to Immunotherapy. Cureus. https://doi.org/10.7759/cureus.110414

Vancouver

Karahan L, Arslan S, Dizdar O. Durable Response to Sotorasib Plus Panitumumab in NRAS G12C-Mutated, Microsatellite Instability-High (MSI-H) Rectal Cancer Refractory to Immunotherapy. Cureus. 2026. doi:10.7759/cureus.110414

BibTeX
@article{Karahan2026,
  author = {Karahan, Latif and Arslan, Sevtap and Dizdar, Omer},
  title = {Durable Response to Sotorasib Plus Panitumumab in NRAS G12C-Mutated, Microsatellite Instability-High (MSI-H) Rectal Cancer Refractory to Immunotherapy},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.110414}
}
Kostenlos starten →